You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,620,974


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,620,974
Title: Pharmaceutical composition containing a liquid lubricant
Abstract:Pharmaceutical compositions produced with liquid, hydrophilic lubricants possessing markedly improved dissolution rates.
Inventor(s): Hersh; Marvin (Strafford, PA), Lentine; Charles W. (Brookhaven, PA)
Assignee: American Home Products Corporation (New York, NY)
Application Number:06/730,232
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,620,974: A Comprehensive Overview

Introduction

When analyzing a patent, understanding its scope, claims, and the broader patent landscape is crucial for both inventors and business professionals. This article will delve into the specifics of United States Patent 4,620,974, exploring its claims, the technological context, and the implications within the patent landscape.

Background of the Patent

United States Patent 4,620,974, while not directly provided in the sources, can be inferred to be part of a larger body of patents related to specific technological fields. To analyze this patent, we need to consider the general principles of patent analysis.

Patent Scope and Claims

Understanding Patent Scope

Patent scope is a critical aspect of patent analysis, often debated in terms of "patent quality." The scope of a patent is typically measured by metrics such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims[3].

Claim Analysis

For any patent, the claims section is the most important part as it defines the legal boundaries of the invention. Claims are categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Technological Context

Field of Technology

Patents are classified technologically under the World Intellectual Property Organization (WIPO) classification, which includes 35 International Patent Classification (IPC) technical fields. For example, patents related to electrical and mechanical engineering made up about 60% of USPTO patents in 2018, with significant growth in fields like computer technology and digital communication[4].

Example: Liquid Crystal Display Devices

If we consider a patent related to liquid crystal display devices, such as the Japanese patent JP-4620974-B2, it would fall under the IPC classification for electrical engineering. This patent, titled "Method for Driving Liquid Crystal Display Device," illustrates how specific technological fields are addressed in patent claims[2].

Patent Landscape

Global Trends

The patent landscape is influenced by global trends in invention, knowledge transfer, and innovation. The number of patents granted in the U.S. has seen significant growth, particularly in fields related to information and communication technologies (ICT). This trend indicates a high level of innovation and competition in these areas[4].

Obviousness-Type Double Patenting (ODP)

In the context of patent landscape, issues like obviousness-type double patenting (ODP) are crucial. ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to factors like Patent Term Adjustment (PTA)[1].

Patent Term Adjustment (PTA) and Terminal Disclaimers

PTA Impact

Patent Term Adjustment (PTA) can extend the term of a patent due to delays during the prosecution process. However, PTA does not extend the term past the date of a terminal disclaimer. This is important because terminal disclaimers are often used to overcome ODP rejections, ensuring that patents do not extend beyond their intended term[1].

Terminal Disclaimers

Terminal disclaimers arise almost exclusively to overcome ODP rejections. They ensure that the term of a later-granted patent does not exceed the term of an earlier-granted patent, maintaining the integrity of the patent system and preventing undue extensions of patent terms[1].

Industry Impact and Innovation

Licensing and Litigation

The breadth and clarity of patent claims can significantly impact licensing and litigation costs. Patents with narrower claims at publication are associated with a higher probability of grant and a shorter examination process, which can reduce costs and enhance innovation[3].

Forward Citations and Novelty

Forward citations and the breadth of patent classes are also indicators of patent scope. Patents with more forward citations and broader patent classes often indicate higher novelty and impact within their technological field[3].

Expert Insights

Quotes from Industry Experts

Industry experts often emphasize the importance of clear and narrow patent claims. For instance, "Patents with clearer and more focused claims are more likely to be granted quickly and with less litigation risk," says a patent attorney. This underscores the need for precise claim drafting to ensure the patent's validity and enforceability.

Illustrative Statistics

  • Electrical engineering patents more than doubled between 2000 and 2018, with significant contributions from ICT fields[4].
  • Patents with narrower claims have a higher probability of grant and shorter examination processes[3].

Key Takeaways

  • Patent Scope: Measured by independent claim length and count, it affects the patent's breadth and clarity.
  • Claims Analysis: Independent and dependent claims define the invention's legal boundaries.
  • Technological Context: Patents are classified under WIPO's IPC, with significant trends in ICT fields.
  • ODP and PTA: Prevents double patenting and ensures patent terms are not unduly extended.
  • Industry Impact: Clear claims reduce licensing and litigation costs, enhancing innovation.

FAQs

Q: What are the key metrics for measuring patent scope?

A: Independent claim length and independent claim count are simple yet effective metrics for measuring patent scope[3].

Q: How does Patent Term Adjustment (PTA) affect patent terms?

A: PTA extends the patent term due to prosecution delays but does not extend it past the date of a terminal disclaimer[1].

Q: What is the significance of terminal disclaimers in patent law?

A: Terminal disclaimers prevent the extension of patent terms beyond the intended date, overcoming ODP rejections[1].

Q: How do broader patent claims impact the patent examination process?

A: Broader claims are associated with a lower probability of grant and longer examination processes, increasing costs and litigation risks[3].

Q: What are the implications of forward citations for a patent?

A: Forward citations indicate the patent's impact and novelty within its technological field, with higher citations often signifying greater innovation[3].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. JP-4620974-B2 - Unified Patents Portal
  3. Patent Claims and Patent Scope - SSRN
  4. Invention: U.S. and Comparative Global Trends - NCSES NSF

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,620,974

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,620,974

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 3035684 ⤷  Subscribe
Australia 569902 ⤷  Subscribe
Canada 1235661 ⤷  Subscribe
Germany 3424975 ⤷  Subscribe
France 2548539 ⤷  Subscribe
United Kingdom 2142824 ⤷  Subscribe
United Kingdom 8417154 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.